Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.09 CHF | +0.75% | +3.78% | 0.00% |
05-03 | Dr. Reddy's Laboratories Launches Generic Doxycycline Capsules in US | MT |
04-30 | CVC weighs options for DKV Mobility stake as IPO plans shelved, sources say | RE |
Sales 2024 * | 4.43B 4.02B 355B | Sales 2025 * | 4.96B 4.51B 397B | Capitalization | 18.65B 16.93B 1,493B |
---|---|---|---|---|---|
Net income 2024 * | 218M 198M 17.45B | Net income 2025 * | 468M 425M 37.47B | EV / Sales 2024 * | 4.73 x |
Net Debt 2024 * | 2.31B 2.09B 185B | Net Debt 2025 * | 1.81B 1.64B 145B | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
88.3
x | P/E ratio 2025 * |
37.6
x | Employees | - |
Yield 2024 * |
0.07% | Yield 2025 * |
0.35% | Free-Float | 0% |
Latest transcript on Galderma Group AG
1 day | +0.75% | ||
1 week | +3.78% | ||
Current month | +3.78% | ||
1 month | +11.25% |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 71.09 | +0.75% | 290 617 |
07/05/24 | 70.56 | +0.94% | 166,154 |
06/05/24 | 69.9 | +0.68% | 141,550 |
03/05/24 | 69.43 | +1.15% | 147,821 |
02/05/24 | 68.64 | +0.20% | 277,884 |
Delayed Quote Swiss Exchange, May 08, 2024 at 04:31 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 18.51B | |
-0.80% | 256B | |
+13.43% | 19.79B | |
+1.06% | 11.18B | |
-12.32% | 9.94B | |
+13.59% | 7.55B | |
+14.29% | 6.27B | |
+4.14% | 4.73B | |
-17.73% | 3.95B | |
-11.30% | 3.59B |
- Stock Market
- Equities
- GALD Stock